APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING TO PREDICT ONDANSETRON PHARMACOKINETICS IN CHILDREN

被引：0
|
作者：
Zhou, W. [1 ]
Johnson, T. [2 ]
Bui, K. [1 ]
Cheung, A. [3 ]
Li, J. [1 ]
Xu, H. [1 ]
Al-Huniti, N. [1 ]
Zhou, D. [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
[2] Certara, Sheffield, S Yorkshire, England
[3] AstraZeneca, Cambridge, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-155
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [41] Physiologically based Pharmacokinetic/Pharmacodynamic Modeling (PBPK/PD) of Famotidine in Pregnancy
    Liu, Xiaomei I.
    Green, Dionna J.
    van den Anker, John
    Ahmadzia, Homa K.
    Calderon, Joaquin
    Burckart, Gilbert J.
    Dallmann, Andre
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [42] Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
    Shaik, Abdul Naveed
    Khan, Ansar Ali
    ADMET AND DMPK, 2019, 7 (01): : 1 - 3
  • [43] Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
    Peters, Sheila Annie
    Ungell, Anna-Lena
    Dolgos, Hugues
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 509 - 518
  • [44] Physiologically based pharmacokinetic (PBPK) modeling of perfluorohexane sulfonate (PFHxS) in humans
    Sweeney, Lisa M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2022, 129
  • [45] Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric Patients
    Guo, Guimu
    You, Xiang
    Wu, Wanhong
    Chen, Jiarui
    Ke, Meng
    Lin, Rongfang
    Huang, Pinfang
    Lin, Cuihong
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 724 - 734
  • [46] Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
    Fairman, Kiara
    Li, Miao
    Ning, Baitang
    Lumen, Annie
    BIOCHEMICAL PHARMACOLOGY, 2021, 189
  • [47] Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
    Cuello, W. S.
    Janes, T. A. T.
    Jessee, J. M.
    Venecek, M. A.
    Sawyer, M. E.
    Eklund, C. R.
    Evans, M. V.
    JOURNAL OF TOXICOLOGY, 2012, 2012
  • [48] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [49] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).
    Duan, P.
    Zhao, P.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S16 - S17
  • [50] Pharmacokinetics and Physiologically-Based Pharmacokinetic Modeling of Nanoparticles
    Yang, Raymond S. H.
    Chang, Louis W.
    Yang, Chung Shi
    Lin, Pinpin
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2010, 10 (12) : 8482 - 8490
12345